Overview
Stephan Menz practices practicing medicine in Berlin, Germany.
His clinical expertise encompasses Allan-Herndon-Dudley Syndrome, Hypotonia, and Spinal Muscular Atrophy Type 3.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Stephan Menz
Is Stephan Menz a top-rated expert for Allan-Herndon-Dudley Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Stephan Menz is classified as an Experienced expert for Allan-Herndon-Dudley Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Stephan Menz participate in research or clinical trials?
Yes. Stephan Menz has published 9 articles and abstracts on conditions like Allan-Herndon-Dudley Syndrome. You can view a list of Stephan Menz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Allan-Herndon-Dudley SyndromeMr. Menz isExperienced. Learn about Allan-Herndon-Dudley Syndrome.
- HypotoniaMr. Menz isExperienced. Learn about Hypotonia.
- Spinal Muscular Atrophy Type 3Mr. Menz isExperienced. Learn about Spinal Muscular Atrophy Type 3.